Thus, considering this accumulation of data and the fact that obese people with signs and symptoms of HF but with low levels of BNP have been generally excluded from many trials [7,81], a new obesity-related HFpEF phenotype has been proposed [6,74]. Here, NPPB is linked to obesity due to melanocortin 4 receptor deficiency.